The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia

Journal of Lipid Research

Volumn 44, Issue 6, 2003, Pages 1251-1255

  Hovingh, G Kees ^a   Van Wijland, Michel J A ^a   Brownlie, Alison ^b   Bisoendial, Radjesh J ^a   Hayden, Michael R ^c   Kastelein, John J P ^a   Groen, Albert K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Xenon Genetics Inc   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ATP binding cassette transporter A1; High density lipoprotein; Methyl cyclodextrin

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CARRIER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHYL BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FAMILIAL HYPOALPHALIPOPROTEINEMIA; FEMALE; GENE MUTATION; HEREDITY; HUMAN; HUMAN CELL; HYPOLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL;

AGED; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BETA-CYCLODEXTRINS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYCLODEXTRINS; FIBROBLASTS; HUMANS; MIDDLE AGED; MUTATION; TANGIER DISEASE; TRIGLYCERIDES;

EID: 0041662842     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300080-JLR200     Document Type: Article

References (21)

1. Glomset, J. A. 1973. The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology. Adv. Lipid Res. 11: 1-65.
2. Rust, S., M. Rosier, H. Funke, J. Real, Z. Amoura, J. C. Piette, J. F. Deleuze, H. B. Brewer, N. Duverger, P. Denefle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22: 352-355.
3. Bodzioch, M., E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W. E. Kaminski, H. W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K. J. Lackner, and G. Schmitz. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351.
4. Brooks-Wilson, A., M. Marcil, S. M. Clee, L. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, and M. R. Hayden. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22: 336-345.
5. Wellington, C. L., E. K. Walker, A. Suarez, A. Kwok, N. Bissada, R. Singaraja, Y. Z. Yang, L. H. Zhang, E. James, J. E. Wilson, O. Francone, B. M. McManus, and M. R. Hayden. 2002. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab. Invest. 82: 273-283.
6. Walter, M., U. Gerdes, U. Seedorf, and G. Assmann. 1994. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205: 850-856.
7. Francis, G. A., R. H. Knopp, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96: 78-87.
8. Remaley, A. T., U. K. Schumacher, J. A. Stonik, B. D. Farsi, H. Nazih, and H. B. Brewer, Jr. 1997. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17: 1813-1821.
9. van Dam, M. J., E. de Groot, S. M. Clee, G. K. Hovingh, R. Roelants, A. Brooks-Wilson, A. H. Zwinderman, A. J. Smit, A. H. Smelt, A. K. Groen, M. R. Hayden, and J. J. Kastelein. 2002. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet. 359: 37-42.
10. Serfaty-Lacrosniere, C., F. Civeira, A. Lanzberg, P. Isaia, J. Berg, E. D. Janus, M. P. Smith, Jr., P. H. Pritchard, J. Frohlich, and R. S. Lees. 1994. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107: 85-98.
11. Asztalos, B. F., M. E. Brousseau, J. R. McNamara, K. V. Horvath, P. S. Roheim, and E. J. Schaefer. 2001. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis. 156: 217-225.
12. Clee, S. M., J. J. Kastelein, M. van Dam, M. Marcil, K. Roomp, K. Y. Zwarts, J. A. Collins, R. Roelants, N. Tamasawa, T. Stulc, T. Suda, R. Ceska, B. Boucher, C. Rondeau, C. DeSouich, A. Brooks-Wilson, H. O. Molhuizen, J. Frohlich, J. Genest, Jr., and M. R. Hayden. 2000. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest. 106: 1263-1270.
13. Singaraja, R. R., C. Fievet, G. Castro, E. R. James, N. Hennuyer, S. M. Clee, N. Bissada, J. C. Choy, J. C. Fruchart, B. M. McManus, B. Staels, and M. R. Hayden. 2002. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110: 35-42.
14. Aiello, R. J., D. Brees, P. A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22: 630-637.
15. Mott, S., L. Yu, M. Marcil, B. Boucher, C. Rondeau, and J. Genest, Jr. 2000. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Atherosclerosis. 152: 457-468.
16. Marcil, M., A. Brooks-Wilson, S. M. Clee, K. Roomp, L. H. Zhang, L. Yu, J. A. Collins, M. van Dam, H. O. Molhuizen, O. Loubster, B. F. Ouellette, C. W. Sensen, K. Fichter, S. Mott, M. Denis, B. Boucher, S. Pimstone, J. Genest, Jr., J. J. Kastelein, and M. R. Hayden. 1999. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354: 1341-1346.
17. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
18. Wellington, C. L., Y. Z. Yang, S. Zhou, S. M. Clee, B. Tan, K. Hirano, K. Zwarts, A. Kwok, A. Gelfer, M. Marcil, S. Newman, K. Roomp, R. Singaraja, J. Collins, L. H. Zhang, A. K. Groen, K. Hovingh, A. Brownlie, S. Tafuri, J. Genest, Jr., J. J. Kastelein, and M. R. Hayden. 2002. Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol. J. Lipid Res. 43: 1939-1949.
19. Kakko, S., J. Kelloniemi, P. von Rohr, I. Hoeschele, M. Tamminen, M. E. Brousseau, Y. A. Kesaniemi, and M. J. Savolainen. 2003. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis. 166: 285-290.
20. Christian, A. E., M. P. Haynes, M. C. Phillips, and G. H. Rothblat. 1997. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38: 2264-2272.
21. Steck, T. L., J. Ye, and Y. Lange. 2002. Probing red cell membrane cholesterol movement with cyclodextrin. Biophys. J. 83: 2118-2125.